Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: Which is better?

Ildiko Lingvay, Jaime L. Legendre, Polina F. Kaloyanova, Song Zhang, Beverley A Huet, Philip Raskin

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Fingerprint

Dive into the research topics of 'Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: Which is better?'. Together they form a unique fingerprint.

Medicine & Life Sciences